Company Filing History:
Years Active: 1999
Title: The Innovative Contributions of Karol La Croix
Introduction
Karol La Croix is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that enhance mucociliary clearance in the human airways.
Latest Patents
La Croix holds a patent for a sterilized, isotonic, and pH-adjusted pharmaceutical formulation. This novel formulation of uridine 5'-triphosphate (UTP) is designed to promote increased mucociliary clearance of retained mucous secretions in the human airways, middle/inner ears, or sinuses. The composition includes UTP and an aqueous solution with a therapeutic concentration between 5 and 35 mg/mL. It maintains controlled tonicity within the range of 250 to 1000 mOsM and is pH-adjusted to a range between 7.0 and 7.5. The formulation is capable of long-term storage in a refrigerated state, with a shelf life of up to 30 months when kept at 5°C. It can be delivered therapeutically in either a nebulized form or liquid form.
Career Highlights
Karol La Croix is currently associated with Inspire Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on improving therapeutic options for patients suffering from respiratory issues.
Collaborations
La Croix has collaborated with notable colleagues such as Christy L. Shaffer and Karla M. Jacobus, contributing to advancements in pharmaceutical formulations and therapies.
Conclusion
Karol La Croix's innovative work in developing a novel pharmaceutical formulation demonstrates his commitment to enhancing patient care through scientific advancements. His contributions are significant in the field of respiratory health and continue to impact the industry positively.